Advertisement
Small interfering RNA lowered lipoprotein(a) by 94% during six-month follow-up after a single dose
Phase 2b trial of aldosterone synthase inhibitor also finds no benefit from dose escalation
Patient series and bench validation support efficacy and safety of CLEVE procedure
Resection, radiotherapy or ablation?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A scannable graphic recap of our latest data
More than 30% of patients die when early dialysis is needed after surgery
The SPECCIAL study is the first to examine long-term clinical outcomes
Case provides proof of concept, prevents need for future heart transplant
Cleveland Clinic series finds favorable long-term results with this high-risk operation
International experts provide a guide for rapid decision-making focused on transcatheter options
Advertisement
Advertisement